UCB, INC. et al v. AUROBINDO PHARMA LIMITED et al
| New Jersey District Court | |
| Judge: | Claire C Cecchi |
| Case #: | 1:24-cv-11428 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Dec 23, 2024 |
| Last checked: Monday Dec 23, 2024 3:09 PM EST |
|
Defendant
AUROBINDO PHARMA LIMITED
|
|
|
Defendant
AUROBINDO USA, INC.
|
|
|
Defendant
AUROLIFE PHARMA LLC
|
|
|
Plaintiff
LTS LOHMANN THERAPIE-SYSTEME AG
|
Represented By
|
|
Plaintiff
UCB PHARMA GMBH
|
Represented By
|
|
Plaintiff
UCB, INC.
|
Represented By
|
| Docket last updated: 4 hours ago |
| Monday, December 23, 2024 | ||
| 2 | 2
Corporate Disclosure Statement by UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG. (BATON, WILLIAM)
|
|
| 1 | 1
29
pgs
COMPLAINT against AUROBINDO PHARMA LIMITED, AUROBINDO USA, INC., AUROLIFE PHARMA LLC ( Filing and Admin fee $ 405 receipt number ANJDC-15898899), filed by UCB, INC., LTS LOHMANN THERAPIE-SYSTEME AG, UCB PHARMA GMBH.(BATON, WILLIAM)
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Exhibit D,
|
||
|
Att: 5
Civil Cover Sheet
|
||